Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application (Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, Others); Distribution Channel (Patients, Providers, Payers, and Employers) and Geography

Publication Month: Dec 2018 | Report Code: TIPHC00002236 | No. of Pages: 137 | Category: Healthcare IT | Status: Published

UPDATE AVAILABLE ON-DEMAND
Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The digital therapeutics market was valued at US$ 1,993.2 million in 2017 and it is projected to reach US$ 8,941.1 million in 2025; it is expected to grow at a CAGR of 20.8% from 2018-2025.

 

Digital therapeutics provide evidence- based therapeutic intrusions to patients that focusses on the treatment of diseases with the programs, management using the high quality software. Digital therapeutics have made progress in the last few years, harnessing technology for the supplement or potentially replace traditional clinical therapy. They are used independently or in concert with devices, medications, or other therapies for the optimization of patient care and health outcomes. The growth of the digital therapeutics market is attributed to the rising prevalence of chronic diseases, rising pressure on healthcare providers to reduce healthcare costs and rising in the number of partnerships and collaborations in the market. However, cyber threat and rise in data security and researchers can pose major challenges for the growth of global digital therapeutics market.

 

The digital therapeutics market is expected to witness substantial growth post-pandemic. The global healthcare infrastructure has observed that, in order to develop and maintain sustainable healthcare setup, utilization of digital healthcare in such a scenario becomes crucial so that patient can keep a check on their health at home. Moreover, majority of the market players have focused on development of digital health tools to provide improved self-care and to the patients, remote monitoring of the patients and to fight against coronavirus pandemic. In addition, several number of research centers and governments have actively participated in the building of digital technologies which are assisting the healthcare professionals to work efficiently even under the pandemic scenario. These factors will eventually drive the market growth.

 

Lucrative Regions for Digital Therapeutics Market

Lucrative Regions for Digital Therapeutics Market

Get more information on this report :


 

Market Insights


Rising Prevalence of Chronic Diseases to Drive Digital Therapeutics Market Growth

Chronic diseases, including heart disease, stroke, diabetes, and obesity, are the leading causes of death in the world and account for most of the nation’s health care costs. According to report of CDC, in 2018, approximately more than 9% of the population has diabetes, which is the leading cause of kidney failure, lower-limb amputations in US. Moreover, the data also suggests that 1.5 million Americans are diagnosed with diabetes every year in the US. Similar trends for high presence of diabetes are prevalent around other geographies of the globe that include Asia Pacific, Europe, Middle East and Africa. For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation in 2017, south-east Asia is home to approximately one-fifth (19%) of the total diabetes population worldwide.

According to the report of American College of Cardiology Foundation, in 2018, Coronary heart disease (CHD) was the leading cause of deaths attributable to cardiovascular disease (CVD) in the US, which is followed by stroke (16.8%), high BP (9.4%), heart failure (HF) (9.0%), and other CVDs (17.9%). By 2035, approximately 130 million adults in the US population are projected to have some form of CVD. Thus, increasing geriatric population and related chronic diseases are expected to drive the sales of electrosurgical instruments thereby propelling the growth of global electrosurgical devices market over the forecast years.

The obesity rates have been increasing rapidly in developed as well as developing economies across the globe. Factors such as, sedentary life and unhealthy lifestyle are considered to be the major factors for the rise in the number of obese individuals. As per data published by The Organisation for Economic Co-operation, (OECD), in 2015, around 19.5% of the adult population was obese. This rate ranges from less than 6% in Korea and Japan to more than 30% in Hungary, New Zealand, Mexico and the United States. The prevalence has increases rapidly in Australia, Canada, Chile, South Africa and the United Kingdom in the recent decade. Obesity levels are anticipated to be high in the United States, Mexico and England, consisting of around 47%, 39% and 35% of the population respectively by the end of 2030.

Diabetes is a life-threatening disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. According to the International Diabetes Federation (IDF), in 2017, number of people with diabetes in North America was approximately 46 million which is expected to grow at 62 million in 2045. Hence, the rise in the prevalence of chronic diseases is anticipated to drive the market during the forecast period.

 

Application-Based Insights

Based on application, the digital therapeutics market is segmented into respiratory diseases, central nervous system diseases, smoking cessation, musculoskeletal diseases, cardiovascular diseases, diabetes, and other applications. The diabetes segment held the largest market share in 2017.Also, the same segment is estimated to register highest CAGR during the forecast period.

 

Digital Therapeutics Market, by Application – 2017 & 2025


Digital Therapeutics Market, by Application – 2017 & 2025

Get more information on this report :

 

 

 

Distribution Channel-Based Insights

In terms of distribution channel, the global digital therapeutics market is segmented into patients, providers, payers, employers and other distribution channels. The patients segment held the largest share of the market in 2017 and providers segment is estimated to register the highest CAGR during the forecast period.


Strategic Insights

The digital therapeutics market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

 

Digital Therapeutics Market - By Application

  • Diabetes
  • Cardiovascular Diseases
  • Central Nervous System (CNS) Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Musculoskeletal Diseases
  • Other Applications Virtual Assistants

Digital Therapeutics Market - By End User

  • Patients
  • Providers
  • Payers
  • Employers

Digital Therapeutics Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

 

Company Profiles

  • Propeller Health
  • Canary Health
  • Noom, Inc.
  • 2Morrow Inc.
  • Livongo Health
  • Proteus Digital Health
  • WellDoc, Inc.
  • Fitbit, Inc.
  • Omada Health, Inc.
  • Mango Health

 

 

TABLE OF CONTENTS

1. INTRODUCTION 18
1.1 SCOPE OF THE STUDY 18
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 18

2. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY TAKEAWAYS 19

3. GLOBAL DIGITAL THERAPEUTICS MARKET - MARKET LANDSCAPE 21
3.1 OVERVIEW 21
3.2 MARKET SEGMENTATION 21
3.2.1 Global Digital Therapeutics Market- By Application 22
3.2.2 Global Digital Therapeutics Market - By Distribution Channel 22
3.2.3 Global Digital Therapeutics Market - By Geography 23
3.3 PEST ANALYSIS 24
3.3.1 North America - PEST Analysis 24
3.3.2 Europe - PEST Analysis 26
3.3.3 Asia Pacific - PEST Analysis 28
3.3.4 Middle East and Africa (MEA) - PEST Analysis 30
3.3.5 South and Central America - PEST Analysis 32

4. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS 34
4.1 KEY MARKET DRIVERS 34
4.1.1 Rising Prevalence of Chronic Diseases 34
4.1.2 Rising Pressure on Healthcare Providers to Reduce Healthcare Costs 35
4.1.3 Rising in the Number of Partnerships and Collaborations in the Market 35
4.2 KEY MARKET RESTRAINTS 36
4.2.1 Cyber Threat and Rise in Data Security 36
4.3 KEY MARKET OPPORTUNITY 36
4.3.1 Large Number of Undiagnosed Population 36
4.4 FUTURE TREND 38
4.4.1 Increase in the Number of Start Ups 38
4.5 IMPACT ANALYSIS 39

5. DIGITAL THERAPEUTICS MARKET- GLOBAL ANALYSIS 40
5.1 GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN) 40
5.2 GLOBAL DIGITAL THERAPEUTICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 41
5.3 PROMINENT PLAYERS 42
5.4 PERFORMANCE OF KEY PLAYERS 42
5.4.1 Propeller Health 42
5.4.2 CANARY HEALTH 42
5.5 EXPERT OPINIONS 43

6. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS - BY APPLICATION 44
6.1 OVERVIEW 44
6.2 DIABETES MARKET 45
6.2.1 Overview 45
6.2.2 Global Diabetes Market Revenue and Forecasts to 2025 (US$ Mn) 45
6.3 CARDIOVASCULAR DISEASE MARKET 46
6.3.1 Overview 46
6.3.2 Global Cardiovascular Disease Market Revenue and Forecasts to 2025 (US$ Mn) 46
6.4 CENTRAL NERVOUS SYSTEM DISEASE MARKET 47
6.4.1 Overview 47
6.4.2 Global Central Nervous System Disease Market Revenue and Forecasts to 2025 (US$ Mn) 47
6.5 RESPIRATORY DISEASES MARKET 48
6.5.1 Overview 48
6.5.2 Global Respiratory Disease Market Revenue and Forecasts to 2025 (US$ Mn) 48
6.6 SMOKING CESSATION MARKET 49
6.6.1 Overview 49
6.6.2 Global Smoking Cessation Market Revenue and Forecasts to 2025 (US$ Mn) 49
6.7 MUSCULOSKELETAL DISEASE MARKET 50
6.7.1 Overview 50
6.7.2 Global Musculoskeletal Disease Market Revenue and Forecasts to 2025 (US$ Mn) 50
6.8 OTHER APPLICATIONS MARKET 51
6.8.1 Overview 51
6.8.2 Global Other Applications Market Revenue and Forecasts to 2025 (US$ Mn) 51

7. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS - BY DISTRIBUTION CHANNEL 52
7.1 OVERVIEW 52
7.2 PATIENTS MARKET 53
7.2.1 Overview 53
7.2.2 Global Patients Market Revenue and Forecasts to 2025 (US$ Mn) 53
7.3 PROVIDERS MARKET 54
7.3.1 Overview 54
7.3.2 Global Providers Market Revenue and Forecasts to 2025 (US$ Mn) 54
7.4 PAYERS MARKET 55
7.4.1 Overview 55
7.4.2 Global Payers Market Revenue and Forecasts to 2025 (US$ Mn) 55
7.5 EMPLOYERS MARKET 56
7.5.1 Overview 56
7.5.2 Global Employers Market Revenue and Forecasts to 2025 (US$ Mn) 56

8. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 57
8.1 OVERVIEW 57
8.2 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
8.3 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN) 58
8.4 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY DISTRIBUTION CHANNEL (US$ MN) 59
8.5 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017-2025) (%) 59
8.6 US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
8.6.1 US Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 61
8.6.2 US Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 61
8.6.3 US Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 62
8.7 CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
8.7.1 Canada Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 64
8.7.2 Canada Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 64
8.7.3 Canada Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 65
8.8 MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
8.8.1 Mexico Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 67
8.8.2 Mexico Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 67
8.8.3 Mexico Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 68

9. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 69
9.1 OVERVIEW 69
9.2 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.3 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 70
9.4 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 71
9.5 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 71
9.6 GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
9.6.1 Germany Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 73
9.6.2 Germany Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 73
9.6.3 Germany Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 74
9.7 UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
9.7.1 UK Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 76
9.7.2 UK Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 76
9.7.3 UK Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 77
9.8 FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
9.8.1 France Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 78
9.8.2 France Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 79
9.8.3 France Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 79

10. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 80
10.1 OVERVIEW 80
10.2 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
10.3 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81
10.4 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 82
10.5 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 82
10.6 JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
10.6.1 Japan Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 83
10.6.2 Japan Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84
10.6.3 Japan Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 84
10.7 CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
10.7.1 China Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 86
10.7.2 China Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 86
10.7.3 China Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 87
10.8 INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
10.8.1 India Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 89
10.8.2 India Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 89
10.8.3 India Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 90

11. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 91
11.1 OVERVIEW 91
11.2 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 92
11.3 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
11.4 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 93
11.5 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 93
11.6 UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 94
11.6.1 UAE Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 94
11.6.2 UAE Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 95
11.6.3 UAE Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 95
11.7 SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 96
11.7.1 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 96
11.7.2 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 97
11.7.3 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 97
11.8 SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 98
11.8.1 South Africa Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 98
11.8.2 South Africa Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 99
11.8.3 South Africa Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 99

12. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 100
12.1 OVERVIEW 100
12.2 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
12.3 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 101
12.4 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 102
12.5 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 102
12.6 BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
12.6.1 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 104
12.6.2 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 104
12.6.3 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 105
12.6.4 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Pharmaceutical Service (US$ Mn) 105

13. DIGITAL THERAPEUTICS MARKET-KEY COMPANY PROFILES 106
13.1 PROPELLER HEALTH 106
13.1.1 Key Facts 106
13.1.2 Business Description 106
13.1.3 Financial Overview 107
13.1.4 Product/Services Portfolio 107
13.1.5 SWOT Analysis 107
13.1.6 Key Developments 107
13.2 CANARY HEALTH 109
13.2.1 Key Facts 109
13.2.2 Business Description 109
13.2.3 Financial Overview 109
13.2.4 Product/Service Portfolio 109
13.2.5 SWOT Analysis 110
13.2.6 Key Developments 110
13.3 NOOM, INC. 111
13.3.1 Key Facts 111
13.3.2 Business Description 111
13.3.3 Financial Overview 111
13.3.4 Product/Services Portfolio 111
13.3.5 SWOT Analysis 112
13.3.6 Key Developments 112
13.4 2MORROW INC. 113
13.4.1 Key Facts 113
13.4.2 Business Description 113
13.4.3 Financial Information 113
13.4.4 Product/Services Portfolio 113
13.4.5 SWOT Analysis 114
13.4.6 Key Developments 114
13.5 LIVONGO HEALTH 115
13.5.1 Key Facts 115
13.5.2 Business Description 115
13.5.3 Financial Information 115
13.5.4 Product/Service Portfolio 115
13.5.5 SWOT Analysis 116
13.5.6 Key Developments 116
13.6 PROTEUS DIGITAL HEALTH 118
13.6.1 Key Facts 118
13.6.2 Business Description 118
13.6.3 Financial Information 118
13.6.4 Product/Service Portfolio 118
13.6.5 SWOT Analysis 119
13.6.6 Key Developments 119
13.7 WELLDOC, INC 120
13.7.1 Key Facts 120
13.7.2 Business Description 120
13.7.3 Financial Overview 120
13.7.4 Product/Service Portfolio 120
13.7.5 SWOT Analysis 121
13.7.6 Key Developments 121
13.8 FITBIT, INC. 123
13.8.1 Key Facts 123
13.8.2 Business Description 123
13.8.3 Financial Overview 124
13.8.4 Product/Service Portfolio 124
13.8.5 SWOT Analysis 125
13.8.6 Key Developments 125
13.9 OMADA HEALTH, INC. 128
13.9.1 Key Facts 128
13.9.2 Business Description 128
13.9.3 Financial Overview 128
13.9.4 Product/Service Portfolio 128
13.9.5 SWOT Analysis 129
13.9.6 Key Developments 129
13.10 MANGO HEALTH 130
13.10.1 Key Facts 130
13.10.2 Business Description 130
13.10.3 Financial Overview 130
13.10.4 Product/Service Portfolio 130
13.10.5 SWOT Analysis 131
13.10.6 Key Developments 131

14. APPENDIX 132
14.1 ABOUT THE INSIGHT PARTNERS 132
14.2 GLOSSARY OF TERMS 132
14.3 METHODOLOGY 134
14.4 COVERAGE 135
14.5 SECONDARY RESEARCH 136
14.6 PRIMARY RESEARCH 136

LIST OF TABLES

TABLE 1. PROPORTION OF PEOPLE LIVING WITH DIABETES (20-79 YEARS) WHO ARE UNDIAGNOSED PER REGION, 2017 37
TABLE 2. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 58
TABLE 3. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 61
TABLE 4. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 62
TABLE 5. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64
TABLE 6. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 65
TABLE 7. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 67
TABLE 8. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 68
TABLE 9. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 70
TABLE 10. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 71
TABLE 11. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 73
TABLE 12. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 74
TABLE 13. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76
TABLE 14. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 77
TABLE 15. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
TABLE 16. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 79
TABLE 17. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81
TABLE 18. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 82
TABLE 19. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
TABLE 20. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 84
TABLE 21. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 86
TABLE 22. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 87
TABLE 23. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 89
TABLE 24. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 90
TABLE 25. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
TABLE 26. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 93
TABLE 27. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 95
TABLE 28. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 95
TABLE 29. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
TABLE 30. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 97
TABLE 31. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 99
TABLE 32. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 99
TABLE 33. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 101
TABLE 34. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 102
TABLE 35. BRAZIL DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104
TABLE 36. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 105
TABLE 37. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY PHARMACEUTICAL SERVICE (US$ MN) 105
TABLE 38. GLOSSARY OF TERMS, DIGITAL THERAPEUTICS MARKET 132

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 19
FIGURE 2. GLOBAL DIGITAL THERAPEUTICS MARKET BY APPLICATION, MARKET SHARE (%), 2017 20
FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, MARKET SHARE (%), 2017 20
FIGURE 4. DIGITAL THERAPEUTICS MARKET SEGMENTATION 21
FIGURE 5. DIGITAL THERAPEUTICS MARKET SEGMENTATION, BY REGION 22
FIGURE 6. NORTH AMERICA PEST ANALYSIS 24
FIGURE 7. EUROPE PEST ANALYSIS 26
FIGURE 8. ASIA PACIFIC PEST ANALYSIS 28
FIGURE 9. MIDDLE EAST AND AFRICA (MEA) PEST ANALYSIS 30
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 32
FIGURE 11. DIGITAL THERAPEUTICS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 39
FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET- REVENUE FORECASTS AND ANALYSIS - 2017- 2025 (US$ MN) 40
FIGURE 13. GLOBAL DIGITAL THERAPEUTICS MARKET- BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 41
FIGURE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SHARES BY APPLICATION, 2017 & 2025 (%) 44
FIGURE 15. GLOBAL DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 16. GLOBAL CARDIOVASCULAR DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
FIGURE 17. GLOBAL CENTRAL NERVOUS SYSTEM DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 18. GLOBAL RESPIRATORY DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 19. GLOBAL SMOKING CESSATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
FIGURE 20. GLOBAL MUSCULOSKELETAL DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 21. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SHARES BY DISTRIBUTION CHANNEL, 2017 & 2025 (%) 52
FIGURE 23. GLOBAL PATIENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 24. GLOBAL PROVIDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 25. GLOBAL PAYERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 26. GLOBAL EMPLOYERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 27. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 57
FIGURE 28. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 29. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017-2025) (%) 59
FIGURE 30. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 31. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
FIGURE 32. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
FIGURE 33. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (%) 69
FIGURE 34. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 35. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 71
FIGURE 36. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 37. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
FIGURE 38. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
FIGURE 39. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017), (US$ MN) 80
FIGURE 40. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
FIGURE 41. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 82
FIGURE 42. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
FIGURE 43. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
FIGURE 44. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
FIGURE 45. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 91
FIGURE 46. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 92
FIGURE 47. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 93
FIGURE 48. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 94
FIGURE 49. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 50. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 98
FIGURE 51. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 100
FIGURE 52. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
FIGURE 53. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 102
FIGURE 54. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104

The List of Companies - Digital Therapeutics Market

1. Propeller Health
2. CANARY HEALTH
3. Noom, Inc.
4. 2Morrow Inc.
5. Livongo Health
6. Proteus Digital Health
7. WellDoc, Inc.
8. Fitbit, Inc.
9. Omada Health, Inc.
10. MANGO HEALTH

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the digital therapeutics market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

 

TIPHC00002236
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing